Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Apixaban vs Enoxaparin/Warfarin in Venous Thromboembolism
2007-007867-25Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of apixaban in venous thromboembolism (VTE), pulmonary embolism (PE) and deep vein thrombosis (DVT) (2 arms), sponsored by Bristol Myers Squibb. Started Jun 2008; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)pulmonary embolism (PE)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on 2007-007867-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007867-25.